Nadège Pelletier
Chief Tech/Sci/R&D Officer at BARINTHUS BIOTHERAPEUTICS PLC
Net worth: - $ as of 2024-03-30
Profile
Nadège Pelletier is currently the Chief Scientific Officer at Barinthus Biotherapeutics Plc.
Prior to this, she worked as a Senior Principal Scientist at Novartis Institutes for Biomedical Research, Inc. She holds a doctorate degree from Université Claude Bernard Lyon 1 and a graduate degree from École Normale Supérieure de Lyon.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-12 | 0 ( -.--% ) | - $ | 2024-03-30 |
Nadège Pelletier active positions
| Companies | Position | Start |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2023-01-31 |
Former positions of Nadège Pelletier
| Companies | Position | End |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Nadège Pelletier
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| École Normale Supérieure de Lyon | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Nadège Pelletier
